Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PTSD prevention using escitalopram

Trial Profile

PTSD prevention using escitalopram

Phase of Trial: Phase II

Latest Information Update: 11 Jul 2017

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Jul 2017 Primary endpoint (Clinician Administered Post-Traumatic Stress Disorder Scale) has not been met, as per the results published in the Journal of Clinical Psychiatry.
    • 11 Jul 2017 Results published in the Journal of Clinical Psychiatry.
    • 03 Jan 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top